Sexual and gender-based violence among adolescents and young adults in refugee settlements and host communities: A case of Palorinya Refugee Settlement in Obongi District, Uganda
Public Health · 2024
DOI: 10.1016/j.puhe.2024.09.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health, 2024. Verfasst von Nazarius Mbona Tumwesigye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Makerere University School of Public Health, Uganda. Electronic address: naz@musph.ac.ug. Hauptthemen laut MEDLINE: Refugees, Sex Offenses, Gender-Based Violence. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This study established the prevalence and correlates of Sexual and Gender-Based Violence (SGBV) among adolescents and young adults aged 13-24 in refugee and host communities in Obongi District of Uganda as of June 2022. STUDY DESIGN: The study was cross-sectional and the participants were adolescents (13-19 years) and young adults (20-24 years) in both refugee and host communities. METHODS: Using a stratified sampling technique 801 participants were identified in the settlement's five zones and interviewed using a semi-structured questionnaire. The main outcome of interest was the experience of SGBV in previous 12 months and factors associated with it were determined using modified Poisson multivariable regression analysis technique. RESULTS: Most of the respondents (82.7 %) perceived SGBV occurred in their community and 13.6 % reported that they had experienced it in the previous 12 months. However, less than half (48 %) of those who experienced it reported the incident to the police or other authorities. Factors significantly associated with SGBV were being female (APR = 1.70, 95 % CI: 1.08-2.70), attaining vocational/tertiary education (APR = 2.18, 95 % CI: 1.02-4.69), being married [monogamous marriage (APR = 2.64, 95 % CI: 1.53-4.55), polygamous marriage (APR = 3.58, 95%CI: 1.86-6.89)], and being Ugandan (APR = 2.20, 95 % CI: 1.33-3.63). CONCLUSION: The findings highlight a concerning prevalence of SGBV among adolescents and young adults within both refugee and host communities, compounded by substantial under-reporting to authorities. Urgent attention is needed to implement targeted interventions that prioritize the protection of women, married individuals, and Ugandan households in and around settlements, while also providing comprehensive support for survivors. Further research should be conducted to explore the connection between tertiary education and SGBV to inform prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Makerere University School of Public Health, Uganda. Electronic address: naz@musph.ac.ug.
- Makerere University School of Public Health, Uganda.
- ChildFund Uganda, Uganda.
- ChildFund International, USA.
Zitieren
APA
Tumwesigye, N. M., Biribawa, C., Namanda, C., Mwebesa, E., Muhumuza, J., Muzamiru, T., Luwaga, C., Dowling, R., & Otai, M. (2024). Sexual and gender-based violence among adolescents and young adults in refugee settlements and host communities: A case of Palorinya Refugee Settlement in Obongi District, Uganda. Public Health. https://doi.org/10.1016/j.puhe.2024.09.014
Vancouver
Tumwesigye NM, Biribawa C, Namanda C, Mwebesa E, Muhumuza J, Muzamiru T, et al. Sexual and gender-based violence among adolescents and young adults in refugee settlements and host communities: A case of Palorinya Refugee Settlement in Obongi District, Uganda. Public Health. 2024. doi:10.1016/j.puhe.2024.09.014
BibTeX
@article{Tumwesigye2024,
author = {Tumwesigye, Nazarius Mbona and Biribawa, Claire and Namanda, Cissie and Mwebesa, Edson and Muhumuza, James and Muzamiru, Tumwine and Luwaga, Charles and Dowling, Russell and Otai, Moses},
title = {Sexual and gender-based violence among adolescents and young adults in refugee settlements and host communities: A case of Palorinya Refugee Settlement in Obongi District, Uganda},
journal = {Public Health},
year = {2024},
doi = {10.1016/j.puhe.2024.09.014}
}
EUVIMED